Navigation Links
New Hepatitis C Drug Shows Promise

The US-based Vertex Pharmaceuticals Incorporated, a global biotechnology company, has released// promising early results of a trial on new hepatitis C drug, telaprevir. The drug could significantly reduce the treatment time, it has been shown.

The planned interim results of the clinical trial on telaprevir were announced at Barcelona on Saturday at the 42nd Annual Meeting of the European Association for the Study of the Liver (EASL).

This drug has an enormous amount of promise," Dr. Ira Jacobson, one of the study's lead investigators, said in a telephone interview. "I think treatments like this will radically alter our perception of optimal duration of therapy for hepatitis C."

Hepatitis C is a liver disease caused by the hepatitis C virus, which is found in the liver and blood of people with the disease. A serious public health concern affecting 3.4 million individuals in the United States, is spread primarily through direct contact with the blood of infected people. Though many people with hepatitis C may not experience symptoms nor be aware of their infection, others may have symptoms such as jaundice and fatigue.

Hepatitis C significantly increases a person's risk for developing chronic liver disease, cirrhosis, the need for liver transplantation, liver cancer, or death.

According to the World Health Organization, the Hepatitis C virus is a major cause of acute hepatitis and chronic liver disease, including cirrhosis and liver cancer.

It is estimated that 170 million people throughout the world are chronically infected with Hepatitis C (9 million in Europe), with 3 to 4 million new infections a year worldwide.

Hepatitis C is spread mostly by direct contact with human blood as a result of blood transfusions and re-using non-sterilized needles and syringes.

The Vertex trial showed a high rate of rapid viral response (RVR) in patients treated with telaprevir, and a low
'"/>




Page: 1 2

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Hepatitis Drug Shows Promise

(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
... effects of coffee, coffee drinkers finally have s...t people// who drink one to three cups of coffee a...is research was part of the Iowa Women's Health St...t of antioxidants which help in the battle against...
... set up an ultra-modern medical college and hospit... said his desire to turn the Mata Janki Kunwar Hos... and hospital was part of his goal to see Bihar on...ould love to help and ensure better medical facili...
...creased its health budget by over 30 percent for t...new medical college//. "In a bid to provide better...the medical education department budget to about R...more than the previous year's Rs.1.16 billion," an...
...lesterol have been found to be useful for the eyes...ol statin drugs are helpful in improving// the blo...risk of diabetic retinopathy and other eye disease...rg, the Japanese study included 12 healthy men, av...
Other Medicine News:
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/8/2008)...study shows clinical improvement in patients with ...Current treatment options have limited benefit for...ncurable blood vessel disease, -- Imatinib mesy...tain cancers, known to inhibit protein associ...otential of imatinib mesylate in PAH in 2009 ...
(Date:10/7/2008)...ct. 7 /- McLaren Health Care and its ... the world,s leading medical,minds to share the la...gastrointestinal cancer treatments. The October 11...nized by McLaren,s Sukamal Saha, M.D., an,award-wi...ode mapping for,colorectal cancer has gained world...
(Date:10/7/2008)...Oct. 7 /- The Texas Cardiac Arrhythmi...as been selected as one of,only a few sites in the...,trial for a new device to treat persistent atrial...raining and research center specializing in heart,...id,s Medical Center and,Texas Cardiovascular Consu...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Closeness is not a problem 3A New ways to handle spatial dependencies in species distributions 1308 1The Advisory Board Company to Present at CIBC World Markets Mid 26 Small Cap Best Ideas Conference 6794 1Susan G Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 6791 1Susan G Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 6791 2Abbott Employees Give Back to Local Communities This Holiday Season 6788 1Abbott Employees Give Back to Local Communities This Holiday Season 6788 2Abbott Employees Give Back to Local Communities This Holiday Season 6788 3
...st Says Study Confirms and Extends Evidence Seen i... /PRNewswire-FirstCall/ --,BioCryst Pharmaceutical...Jude Children,s Research Hospital, Memphis, TN, re...tment in an animal model,of influenza using a high...za strain that had caused fatal human infection in...
...ta show efficacy across the range of migraine symp...any migraine,sufferers experience traditional symp...und, migraine attacks can also involve,symptoms li...lly,associated with migraine headaches. New data s...estigational migraine,treatment Trexima early in t...
Other Medicine Technology:St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 2St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 3St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 4St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 5St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection 6Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 2Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 3Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 4Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms 5
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: